InsidersTradesSigma
Follow the 华森制药 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 华森制药 has logged 5 reports. Market capitalisation: €5.1bn. The latest transaction was filed on 13 January 2026 (Sale). Among the most active insiders: 游洪涛. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
华森制药 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of innovative medications.